Manufacturer record
Vats Biotech Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
5 batches manufactured by Vats Biotech Pvt. Ltd (Himachal Pradesh) were declared Not of Standard Quality between September 2022 and February 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
5 records linked to Vats Biotech Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Cefuroxime Axetil Tablets IP | VCT/459Mfg 2024-06 · Exp 2026-05 | Sample fails the tests Assay and Dissolution as per IP as specified in the Laboratory Protocol.Assay | DTL ThiruvananthapuramState lab | Feb 2026 |
| Aceclofenac, Paracetamol & Chlorzoxazone Tablets | VGT/2201Mfg 2024-04 · Exp 2026-03 | Description and Assay for AceclofenacAssay | RDTL, Bellary, KarnatakaState lab | Jan 2026 |
| Esyfol-XT (Calcium Carbonate, Vitamin D3, Methylcobalamin, L-Methylfolate Calcium & Pyridoxal-5 Phosphate Tablets) | VGT/2088Mfg 2024-03 · Exp 2026-02 | Description and Identification & Assay for Vitamin D3Assay | KarnatakaState lab | Jul 2025 |
| Cefpodoxim e Proxetil Tablets IP 200 MG (RIZDOX- 200) | VCT/129Mfg 2023-08 · Exp 2025-07 | On the received sample Discoloration,rough surface and picking defects were observed which should not be present As per DCC Guidelines on Not Of Standard Quality (NSQ) Drugs Approved in 1993 (Annexure A) Tablets vide serial No.(i) Presence of Spot/discoloration (iv)Picking and (vii)Rough surface. - NSQDescription | State Lab PuducherryState lab | Jan 2025 |
| MONTERUS-L (Montelukast Sodium & Levocetirizine Hydrochloride Tablets I.P.) | VBGT-094Mfg 2021-11 · Exp 2023-10 | Dissolution and DescriptionDissolution | RDTL GuwahatiState lab | Sep 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.